Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03667079 · ClinicalTrials.gov registry record · NA
Integrating Community Interventions to Eliminate Neglected Tropical Diseases
A NA study, sponsored by Washington State University.
- Completed
- Registry status
- NA
- Development phase
- 28,143
- Enrollment target
NCT03667079: Completed NA study, sponsored by Washington State University.
NCT03667079 is a NA study that has completed, run by Washington State University. The registered enrollment target is 28,143 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1906% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03667079, a NA study, has completed, sponsored by Washington State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 28,143 participants
- Enrollment target
Study Summary
The overarching goal of this project is the elimination of two neglected tropical diseases (NTD): soil-transmitted helminthiasis and rabies. The specific objective of this pilot study was: To determine whether the integrated delivery platform improved the cost-effectiveness and coverage of MDA targeting STH and rabies; The investigators integrated two public health initiatives: 1) a mass drug administration (MDA) effort to eliminate neglected tropical diseases (NTD) caused by soil-transmitted helminths (STH), with 2) a community-valued mass dog rabies vaccination (MDRV) intervention to eliminate human and animal rabies, also a priority NTD of the World Health Organisation. The goal of MDA efforts targeting STH is to reduce worm burdens to very low levels below which self-sustaining transmission, and the public health consequences of STH, cease. Existing school-based delivery programs fail to reach all affected age groups, however, which results in ineffective coverage levels and persistence of STH. The goal of MDRV is to immunize 70% of dog populations, after which canine-mediated rabies is eliminated. MDRV programs are typically very popular, with all human age groups participating. The objectives of this project were to determine whether supplementing a strictly school-based MDA NTD control program with a community-wide strategy that is coupled to an MDRV program will result in a synergism that (a) improves coverage, reach and cost-effective delivery of MDA targeting STH and (b) improves coverage and cost-effective delivery of dog vaccination. To achieve this, research activities, comprised of post-intervention household questionnaire surveys, were carried out. In addition detailed cost data was collected.
Primary Outcome
The proportion of people in each village receiving deworming treatment was measured using household questionnaire surveys
Interventions
- OTHER integrated delivery of deworming and vaccination
- OTHER Mass deworming only
- OTHER Mass vaccination of dogs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28,143 participants |
| Start Date | 2016-02-01 |
| Est. Completion | 2016-12-31 |
| Phase | NA |
What the finished NCT03667079 record still lists
NCT03667079 is an interventional study that assigns participants to a tested intervention. Its 28,143 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1906% higher).
The record links to 0 conditions, and to 3 interventions - of which integrated delivery of deworming and vaccination is the first listed.
NCT03667079 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03667079 about?
NCT03667079 is a clinical study titled "Integrating Community Interventions to Eliminate Neglected Tropical Diseases". The overarching goal of this project is the elimination of two neglected tropical diseases (NTD): soil-transmitted helminthiasis and rabies. The specific objective of this pilot study was: To determine whether the integrated delivery platform improved the cost-effectiveness and coverage of MDA tar...
What is the current status of trial NCT03667079?
This trial is currently completed. It is a NA study. The enrollment target is 28,143 participants. The study started on 2016-02-01. Estimated completion is 2016-12-31.
What interventions are being tested in trial NCT03667079?
The interventions under investigation include: integrated delivery of deworming and vaccination (OTHER), Mass deworming only (OTHER), Mass vaccination of dogs (OTHER).
Who is sponsoring clinical trial NCT03667079?
This trial is sponsored by Washington State University, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03667079's enrollment target sits among peer trials
28,143 9th of 2000 higher than 1,992 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04494945 · 27,500 participants · NA
Identifying and Caring for Individuals With Inherited Cancer Syndrome
- NCT04678193 · 27,000 participants
COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy
- NCT00684580 · 30,000 participants
Protocol For Collecting Data On Patients With Childhood Cancer
- NCT03053193 · 30,000 participants
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI